Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.

Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, Koirala J, Szymczak A, Lundgren J, Ross MJ, Wyatt CM; INSIGHT SMART Study Group; ESPRIT Study Group.

PLoS One. 2012;7(7):e40245. Epub 2012 Jul 20.

2.

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.

Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, Grzeszczuk A, Sambatakou H, Mocroft A, Kirk O; EuroSIDA in EuroCoord.

AIDS. 2012 Sep 24;26(15):1917-26.

PMID:
22781222
3.

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.

Rossi C, Raboud J, Walmsley S, Cooper C, Antoniou T, Burchell AN, Hull M, Chia J, Hogg RS, Moodie EE, Klein MB; Canadian Observational Cohort (CANOC) Collaboration.

BMC Infect Dis. 2017 Apr 4;17(1):246. doi: 10.1186/s12879-017-2350-8.

4.

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.

Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA; NA-ACCORD of the IeDEA.

J Infect Dis. 2013 Oct 15;208(8):1240-9. doi: 10.1093/infdis/jit373. Epub 2013 Jul 31.

5.

Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.

Lee JJ, Lin MY, Yang YH, Lu SN, Chen HC, Hwang SJ.

Am J Kidney Dis. 2010 Jul;56(1):23-31. doi: 10.1053/j.ajkd.2010.01.015. Epub 2010 Apr 18.

PMID:
20400217
6.

Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.

Kruse RL, Kramer JR, Tyson GL, Duan Z, Chen L, El-Serag HB, Kanwal F.

Hepatology. 2014 Dec;60(6):1871-8. doi: 10.1002/hep.27337. Epub 2014 Oct 29.

7.

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; EuroSIDA in EuroCoord.

J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005. Epub 2013 Apr 11.

PMID:
23583272
8.

Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.

Fabbri G, Mastrorosa I, Vergori A, Mazzotta V, Pinnetti C, Grisetti S, Zaccarelli M, Ammassari A, Antinori A.

BMC Infect Dis. 2017 Mar 1;17(1):182. doi: 10.1186/s12879-017-2287-y. Review.

9.

High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.

Rusine J, Ondoa P, Asiimwe-Kateera B, Boer KR, Uwimana JM, Mukabayire O, Zaaijer H, Mugabekazi J, Reiss P, van de Wijgert JH.

PLoS One. 2013 May 22;8(5):e63303. doi: 10.1371/journal.pone.0063303. Print 2013.

10.

Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.

Bahirwani R, Barin B, Olthoff K, Stock P, Murphy B, Rajender Reddy K; Solid Organ Transplantation in HIV: Multi-Site Study Investigators.

Liver Transpl. 2013 Jun;19(6):619-26. doi: 10.1002/lt.23648.

11.

Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.

Fabrizi F, Dixit V, Martin P, Messa P.

J Med Virol. 2016 Mar;88(3):487-97. doi: 10.1002/jmv.24353. Epub 2015 Oct 8. Review.

PMID:
26271205
12.

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.

Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, Krishnasami Z, Willig JH, Martin JN, Moore RD, Eron JJ, Kitahata MM.

AIDS. 2012 Sep 24;26(15):1907-15.

13.

Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.

Mederacke I, Meier M, Lüth JB, Schmidt-Gürtler H, Raupach R, Horn-Wichmann R, Wursthorn K, Potthoff A, Colucci G, Manns MP, Wedemeyer H, Tillmann HL.

Nephrol Dial Transplant. 2011 Aug;26(8):2648-56. doi: 10.1093/ndt/gfq757. Epub 2011 Jan 27.

PMID:
21273235
14.

Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients.

Filippini P, Coppola N, Pisapia R, Martini S, Marrocco C, Di Martino F, Sagnelli C, Filippini A, Sagnelli E.

J Med Virol. 2007 Nov;79(11):1679-85.

PMID:
17854026
15.

Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.

Rogal SS, Yan P, Rimland D, Lo Re V 3rd, Al-Rowais H, Fried L, Butt AA; Electronically Retrieved Cohort of HCV Infected Veterans Study Group.

Dig Dis Sci. 2016 Mar;61(3):930-6. doi: 10.1007/s10620-015-3918-z. Epub 2015 Nov 2.

PMID:
26526451
16.

HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.

Bailey H, Nizova N, Martsynovska V, Volokha A, Malyuta R, Cortina-Borja M, Thorne C; Ukraine European Collaborative Study in EuroCoord.

BMC Infect Dis. 2016 Dec 12;16(1):755.

17.

The APOBEC3B deletion polymorphism is associated with prevalence of hepatitis B virus, hepatitis C virus, Torque Teno virus, and Toxoplasma gondii co-infection among HIV-infected individuals.

Prasetyo AA, Sariyatun R, Reviono, Sari Y, Hudiyono, Haryati S, Adnan ZA, Hartono, Kageyama S.

J Clin Virol. 2015 Sep;70:67-71. doi: 10.1016/j.jcv.2015.07.009. Epub 2015 Jul 8.

PMID:
26305823
18.

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group.

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.

19.

Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.

Yu G, Chi X, Wu R, Wang X, Gao X, Kong F, Feng X, Gao Y, Huang X, Jin J, Qi Y, Tu Z, Sun B, Zhong J, Pan Y, Niu J.

PLoS One. 2015 Sep 30;10(9):e0139015. doi: 10.1371/journal.pone.0139015. eCollection 2015.

20.

Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.

Tsui J, Vittinghoff E, Anastos K, Augenbraun M, Young M, Nowicki M, Cohen MH, Peters MG, Golub ET, Szczech L.

Am J Kidney Dis. 2009 Jul;54(1):43-50. doi: 10.1053/j.ajkd.2009.02.009. Epub 2009 Apr 25.

Supplemental Content

Support Center